45 results
-
List item
National expert: Armando Magrelli, Italian Medicines Agency (updated)
- Declaration of interests - 79.78 KB | PDF
- Curriculum Vitae - 27.51 KB | PDF
Computer systems analyst Con Soluzioni Con Srl (Italy) Main activities … -
List item
National expert: Angela Del Vecchio, Italian Medicines Agency (updated)
- Declaration of interests - 80.03 KB | PDF
- Curriculum Vitae - 18.58 KB | PDF
Vecchio A. Le Procedure per il rilascio dellesenzione dagli accertamenti … -
List item
National expert: Raffaella Sardelli, Italian Medicines Agency (updated)
- Declaration of interests - 80.05 KB | PDF
- Curriculum Vitae - 22.65 KB | PDF
Contaminazione da alluminio in soluzioni di albumina umana: un monitoraggio … dellattivatore della precallicreina in soluzioni di albumina umana (Abs) La … -
List item
National expert: Eraldo Donnarumma, Italian Medicines Agency (updated)
- Declaration of interests - 79.76 KB | PDF
- Curriculum Vitae - 17.73 KB | PDF
PANORAMI E PERCORSI) Doping: soluzione o inganno chimico? (BIF n.4/2006 … -
List item
National expert: Tiziana Forte, Ministry for Health (updated)
- Declaration of interests - 79.75 KB | PDF
- Curriculum Vitae - 23.73 KB | PDF
settembre 2002; Acquisto soluzioni infusionali: parametri di … -
List item
Referral: Plendil and associated names
felodipine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 16/12/2014, Last updated: 30/03/2015 -
List item
Referral: Losec
omeprazole, associated names: Antra, Logastric, Losec Forte, Mopral, Omeprazen, Omeprazole, AstraZeneca, Zoltum, Article 30 referrals
Status: European Commission final decision, opinion/position date: 20/01/2010, EC decision date: 10/06/2010, Last updated: 19/09/2011 -
List item
Herbal medicinal product: Myrtilli fructus recens
Vaccinium myrtillus L., Fresh Bilberry fruit, F: Assessment finalised, Last updated: 16/12/2015 -
List item
Herbal medicinal product: Myrtilli fructus siccus
Vaccinium myrtillus L., Dried Bilberry fruit, F: Assessment finalised, Last updated: 16/12/2015 -
List item
Referral: Seroquel XR
quetiapine, Article 6(13) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 22/04/2010, EC decision date: 26/08/2010, Last updated: 19/11/2010 -
List item
Referral: Cyproterone- and ethinylestradiol-containing medicines
cyproterone / ethinylestradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013 -
List item
Orphan designation: Fluocinolone acetonide for: Treatment of non-infectious uveitis affecting the posterior segment of the eye
Date of first decision: 07/03/2005, Positive, Last updated: 30/05/2007 -
List item
Referral: Closamectin Pour-on Solution and associated names
Ivermectin, closantel, Article 78
Status: European Commission final decision, opinion/position date: 08/10/2015, EC decision date: 22/03/2016, Last updated: 31/05/2016 -
List item
Referral: Tylosin injection for mastitis
tylosin, Article 35
Status: European Commission final decision, opinion/position date: 16/03/2017, EC decision date: 10/07/2017, Last updated: 31/07/2017 -
List item
Referral: Fiprex
fipronil, Article 33
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 14/07/2014, Last updated: 14/08/2014 -
List item
Referral: Baytril injectable and generics
enrofloxacin, Article 35
Status: European Commission final decision, opinion/position date: 09/04/2014, EC decision date: 01/09/2014, Last updated: 10/12/2014 -
List item
Referral: Moxidectin-containing veterinary medicines used in cattle, sheep and horses
moxidectin, associated names: See annex I, Article 35
Status: European Commission final decision, opinion/position date: 11/05/2017, EC decision date: 26/09/2017, Last updated: 24/10/2017 -
List item
Referral: Seroquel / Seroquel XR and associated names
quetiapine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 09/09/2014 -
List item
Referral: Altrenogest
n/a, Article 35
Status: European Commission final decision, opinion/position date: 19/05/2016, EC decision date: 29/07/2016, Last updated: 08/09/2016 -
List item
Referral: Ivermectin
Ivermectin, Article 35
Status: European Commission final decision, opinion/position date: 05/06/2009, EC decision date: 01/10/2009, Last updated: 26/10/2009 -
List item
Referral: Zyrtec
cetirizine, Article 30 referrals
Status: European Commission final decision, opinion/position date: 30/05/2008, EC decision date: 06/10/2008, Last updated: 16/10/2008 -
List item
Referral: Baxter dialysis solutions
Baxter dialysis solutions, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/10/2011, EC decision date: 16/12/2011, Last updated: 20/11/2013 -
List item
Referral: Cydectin TriclaMox
moxidectin / triclabendazole, Article 13
Status: European Commission final decision, opinion/position date: 16/07/2013, EC decision date: 25/09/2013, Last updated: 18/10/2013TriclaMox 5 mg/ml + 200 mg/ml soluzione Pour-on per bovini Moxidectin … -
List item
Referral: Ciprofloxacin Hikma
ciprofloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/01/2007, EC decision date: 11/06/2007, Last updated: 06/09/2007Ciprofloxacin Hikma 200mg/100ml Soluzione per Infusione Endovenosa … -
List item
Referral: Girolan and its associated name Apralan
apramycin sulfate, associated names: Apralan, Article 34
Status: European Commission final decision, opinion/position date: 15/02/2018, EC decision date: 08/05/2018, Last updated: 15/06/2018Apralan Solubile polvere per soluzione orale per Suini, Polli da …